UPDATED Apr 25, 2024
Discover Belgian Growth Stocks that are on the BEL20. Sorted by forecasted growth, these stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ATEB | €5.93 | -3.1% | -86.8% | €257.5m | €13.40 | PS2.9x | E118.6% | 0% | Real Estate Management and Development | ||
BANI | €3.78 | 12.5% | -2.6% | €42.5m | €4.50 | PS6.8x | E111.5% | 0% | Real Estate Management and Development | ||
IMMO | €26.00 | -2.4% | -42.5% | €259.3m | €46.00 | PS1.7x | E110.8% | 4.6% | Real Estate Management and Development | ||
CPINV | €13.12 | -0.9% | -3.8% | €485.3m | €15.13 | PB0.8x | E109.4% | 7.6% | Real Estate | ||
MITRA | €0.22 | -1.8% | -92.3% | €15.2m | n/a | PE-0.09x | E105.1% | 0% | Pharmaceuticals & Biotech | ||
BELYS | €0.85 | -2.3% | -19.8% | €30.6m | €1.80 | PB0.4x | E100.2% | 0% | Consumer Durables | ||
INTO | €20.85 | 0% | 11.3% | €642.7m | €21.00 | PB1x | E95.9% | 4.9% | Real Estate | ||
AGFB | €1.16 | 1.8% | -54.5% | €179.3m | €1.83 | PB0.5x | E95.7% | n/a | Healthcare | ||
EKOP | €17.95 | -0.3% | 3.8% | €266.1m | €27.50 | PS7.4x | E93.5% | n/a | Commercial Services | ||
IBAB | €12.96 | -2.3% | -22.0% | €378.1m | €16.17 | PB4.4x | E85.4% | 1.6% | Healthcare | ||
HYSG | €3.62 | 0.6% | -23.3% | €118.9m | €5.15 | PE90.2x | E73.8% | n/a | Software | ||
SEQUA | €1.40 | -2.8% | -58.0% | €50.3m | €5.97 | PS70.6x | E69.0% | n/a | Healthcare | ||
COFB | €61.50 | -1.4% | -29.0% | €2.3b | €72.39 | PB0.6x | E62.5% | 10.1% | Real Estate | ||
AED | €59.20 | 1.2% | -21.8% | €2.8b | €66.13 | PB0.8x | E61.7% | 6.6% | Real Estate | ||
RECT | €11.98 | 3.1% | -7.3% | €669.7m | €12.83 | PS1.2x | E60.8% | 2.6% | Capital Goods | ||
MDXH | €3.02 | -5.6% | -52.3% | €82.4m | €7.70 | PS1.4x | E59.8% | n/a | Pharmaceuticals & Biotech | ||
ARGX | €346.20 | 2.6% | -0.7% | €20.6b | €439.32 | PS17.4x | E56.1% | n/a | Pharmaceuticals & Biotech | ||
HOMI | €16.28 | 2.8% | -17.0% | €319.3m | €17.75 | PB0.8x | E55.4% | 6.9% | Real Estate | ||
UPG | €3.79 | -0.3% | -6.5% | €135.8m | €4.65 | PB1.8x | E50.5% | n/a | Software | ||
HYL | €11.85 | -1.3% | -7.8% | €331.8m | €21.55 | PS117.9x | E42.8% | n/a | Pharmaceuticals & Biotech | ||
OBEL | €14.20 | 1.0% | -3.5% | €851.2m | €18.40 | PE19345.8x | E40.2% | 0% | Telecom | ||
DECB | €2.53 | 0.6% | 7.7% | €350.3m | €3.57 | PE36.9x | E38.1% | 3.2% | Capital Goods | ||
GREEN | €5.20 | 1.2% | -16.1% | €258.5m | €9.02 | PE33.3x | E36.8% | 1.9% | Food, Beverage & Tobacco | ||
XIOR | €25.15 | 1.6% | -12.7% | €961.4m | €33.69 | PB0.6x | E35.9% | 7.0% | Real Estate |